Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Glendon, Gord"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
RAD51B in Familial Breast Cancer.
Autorzy:
Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Vuorela M; Laboratory of Cancer Genetics and Tumor Biology, Cancer Research and Translational Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland.
Kiiski JI; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Vilske S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nevanlinna V; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ranta S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Schleutker J; BioMediTech, University of Tampere, Tampere, Finland.; Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland.; Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer Research and Translational Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland.
Kallioniemi A; BioMediTech, University of Tampere, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Bogdanova NV; Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Rosenberg EH; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, California, United States of America.
Beckmann MW; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Sawyer EJ; Research Oncology, Guy's Hospital, King's College London, London, United Kingdom.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Surowy H; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guénel P; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.; University Paris-Sud, Villejuif, France.
Truong T; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.; University Paris-Sud, Villejuif, France.
Bojesen SE; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nordestgaard BG; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Benitez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain.
González-Neira A; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
Neuhausen SL; Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, United States of America.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Brauch H; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Mannermaa A; Cancer Center, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Hartikainen JM; Cancer Center, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Van Dyck L; Vesalius Research Center, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Janssen H; Leuven Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.
Peterlongo P; IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy.
Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia.; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia.; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada.
Dumont M; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada.
Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway.
Borresen-Dale AL; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Collée M; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Cox A; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Luben RN; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Orr N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Swerdlow A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Mattson J; Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pokaż więcej
Corporate Authors:
kConFab/AOCS Investigators
Źródło:
PloS one [PLoS One] 2016 May 05; Vol. 11 (5), pp. e0153788. Date of Electronic Publication: 2016 May 05 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*genetics
DNA-Binding Proteins/*genetics
Polymorphism, Single Nucleotide/*genetics
Breast Neoplasms/etiology ; DNA-Binding Proteins/physiology ; Female ; Finland ; Genetic Predisposition to Disease/genetics ; Genotyping Techniques ; Haplotypes/genetics ; Heterozygote ; Humans ; Male ; Middle Aged ; Mutation, Missense
SCR Disease Name:
Breast Cancer, Familial
Czasopismo naukowe
Tytuł:
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
Autorzy:
Sawyer E; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Roylance R; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Petridis C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Brook MN; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Nowinski S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Papouli E; Biomedical Research Centre, King's College London, Guy's Hospital, London, United Kingdom.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Pinder S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Hanby A; Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom.
Kohut K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Gorman P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Caneppele M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Peto J; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Dos Santos Silva I; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Swann R; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Dwek M; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Perkins KA; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Gillett C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Ross G; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
De Ieso P; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Hopper JL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Provenzano E; NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, United Kingdom.
Apicella C; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Wesseling J; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Cornelissen S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Keeman R; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Fasching PA; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Jud SM; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Kerin MJ; Surgery, Clinical Science Institute, National University of Ireland, Galway, Ireland.
Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
Kerbrat P; Centre Eugène Marquis, Department of Medical Oncology, Rennes, France.
Bojesen SE; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Nordestgaard BG; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Nielsen SF; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Milne RL; Genetic & Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Lichtner P; Institute of Human Genetics, Technische Universität, Munich, Germany.
Schmutzler RK; Centre for Familial Breast and Ovarian Cancer and Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
Lochmann M; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
Fischer HP; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany.
Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Kataja V; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Institute of Medical Research, Brisbane, Australia.
Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Department of Oncology, University of Leuven, Leuven, Belgium.
Weltens C; University Hospital Gashuisberg, Leuven, Belgium.
Van Limbergen E; University Hospital Gashuisberg, Leuven, Belgium.
Hatse S; University Hospital Gashuisberg, Leuven, Belgium.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
Volorio S; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Giles GG; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Severi G; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Baglietto L; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
McLean CA; Department of Pathology, The Alfred Hospital, Prahran, Victoria, Australia.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Goldberg MS; Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
Labrèche F; Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada.
Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), UiO, Oslo, Norway.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Kauppila S; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Andrulis IL; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Knight JA; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Mulligan AM; Laboratory Medicine Program, University Health Network, Toronto, Ontario; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Devillee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Seynaeve CM; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Kriege M; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Figueroa J; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Chanock SJ; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Sherman ME; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Deurzen CH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore.
Czene K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Humphreys K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Ashworth A; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Orr N; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Schoemaker M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
González-Neira A; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Pita G; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Alonso MR; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Tessier DC; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Vincent D; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Bacot F; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Hall P; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Pokaż więcej
Corporate Authors:
GENICA Network
KConFab Investigators; Peter MacCallum Cancer Center, Melbourne, Australia.
Źródło:
PLoS genetics [PLoS Genet] 2014 Apr 17; Vol. 10 (4), pp. e1004285. Date of Electronic Publication: 2014 Apr 17 (Print Publication: 2014).
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Breast Neoplasms/*genetics
Carcinoma in Situ/*genetics
Carcinoma, Lobular/*genetics
Genetic Predisposition to Disease/*genetics
Case-Control Studies ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Middle Aged ; Polymorphism, Single Nucleotide/genetics
Czasopismo naukowe
Tytuł:
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
Autorzy:
Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
Kuchenbaecker K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Vaclová T; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Pita G; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.
Alonso R; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.
Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Blanco I; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
Duran M; Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain.
Díez O; Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain.
Ramón Y Cajal T; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Konstantopoulou I; Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece.
Martínez-Bouzas C; Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain.
Andrés Conejero R; Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain.
Soucy P; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada.
McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Arver B; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Loman N; Department of Oncology, Lund University Hospital, Lund, Sweden.
Ehrencrona H; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America.
Beattie MS; Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America.
Domchek SM; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Nathanson K; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Rebbeck TR; Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Arun BK; University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.
Whittemore AS; Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America.
Daly MB; Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia.
Hopper J; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia.
Terry MB; Department of Epidemiology, Columbia University, New York, New York, United States of America.
Buys SS; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania.
Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa.
van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa.
Steele L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jønson L; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Ejlertsen B; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Infante M; Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain.
Herráez B; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.
Moreno LT; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.
Weitzel JN; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Herzog J; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Weeman K; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Zaffaroni D; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Scuvera G; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
Mariette F; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Volorio S; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Viel A; Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy.
Varesco L; Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
Papi L; Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
Ottini L; Department of Molecular Medicine, 'Sapienza' University, Rome, Italy.
Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.
Radice P; Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Yannoukakos D; Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece.
Garber J; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Platte R; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Fineberg E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Evans G; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Lalloo F; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Izatt L; South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom.
Eeles R; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom.
Adlard J; Yorkshire Regional Genetics Service, Leeds, United Kingdom.
Davidson R; Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom.
Cole T; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom.
Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.
Hodgson S; Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom.
Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
Tischkowitz M; Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom.
Douglas F; Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.
Porteous M; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
Side L; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
Walker L; Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom.
Morrison P; Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom.
Donaldson A; South West Regional Genetics Service, Bristol, United Kingdom.
Kennedy J; Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire.
Foo C; Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
Schmutzler RK; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Wappenschmidt B; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Rhiem K; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Ditsch N; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Arnold N; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Plendl HJ; Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Niederacher D; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Preisler-Adams S; Institute of Human Genetics, University of Münster, Münster, Germany.
Kast K; Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
Stoppa-Lyonnet D; Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Sinilnikova OM; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Mazoyer S; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Damiola F; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Poppe B; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Piedmonte M; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Tucker K; Prince of Wales Hospital. Sydney, Australia.
Backes F; Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America.
Rodríguez G; Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America.
Brewster W; Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America.
Wakeley K; For Tufts Medical Center, Boston, Massachusetts, United States of America.
Rutherford T; Yale University School of Medicine, New Haven, Connecticut, United States of America.
Caldés T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Os TA; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
van der Kolk L; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
de Lange JL; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meijers-Heijboer HE; Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands.
van der Hout AH; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands.
Gómez Garcia EB; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands.
Hoogerbrugge N; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Deurzen CH; Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Devilee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Lázaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Teulé A; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Menéndez M; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
Johannsson OT; Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland.
Maugard C; Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France.
Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
Healey S; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia.
Olswold C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Guidugli L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Lindor N; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Szabo CI; Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America.
Vijai J; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Robson M; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Kauff N; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Zhang L; Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Rau-Murthy R; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Fink-Retter A; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Rappaport C; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Geschwantler Kaulich D; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pfeiler G; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tea MK; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Berger A; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America.
Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America.
Lejbkowicz F; Clalit National Israeli Cancer Control Center, Haifa, Israel.
Andrulis I; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Glendon G; Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Toland AE; Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Pedersen IS; Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Sunde L; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Friedman E; Sheba Medical Center, Tel Aviv, Israel.
Laitman Y; Sheba Medical Center, Tel Aviv, Israel.
Shimon SP; Sheba Medical Center, Tel Aviv, Israel.
Simard J; Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Offit K; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Couch FJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Chenevix-Trench G; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Benitez J; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.
Pokaż więcej
Corporate Authors:
SWE-BRCA; Department of Oncology, Lund University, Lund, Sweden.
HEBON; The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands.
KConFab Investigators; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia.
Źródło:
PLoS genetics [PLoS Genet] 2014 Apr 03; Vol. 10 (4), pp. e1004256. Date of Electronic Publication: 2014 Apr 03 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Breast Neoplasms/*genetics
DNA Glycosylases/*genetics
DNA Repair/*genetics
Ovarian Neoplasms/*genetics
Polymorphism, Single Nucleotide/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Middle Aged ; Risk
Czasopismo naukowe
Tytuł:
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
Autorzy:
Nickels S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Truong T
Hein R
Stevens K
Buck K
Behrens S
Eilber U
Schmidt M
Häberle L
Vrieling A
Gaudet M
Figueroa J
Schoof N
Spurdle AB
Rudolph A
Fasching PA
Hopper JL
Makalic E
Schmidt DF
Southey MC
Beckmann MW
Ekici AB
Fletcher O
Gibson L
Silva Idos S
Peto J
Humphreys MK
Wang J
Cordina-Duverger E
Menegaux F
Nordestgaard BG
Bojesen SE
Lanng C
Anton-Culver H
Ziogas A
Bernstein L
Clarke CA
Brenner H
Müller H
Arndt V
Stegmaier C
Brauch H
Brüning T
Harth V
Mannermaa A
Kataja V
Kosma VM
Hartikainen JM
Lambrechts D
Smeets D
Neven P
Paridaens R
Flesch-Janys D
Obi N
Wang-Gohrke S
Couch FJ
Olson JE
Vachon CM
Giles GG
Severi G
Baglietto L
Offit K
John EM
Miron A
Andrulis IL
Knight JA
Glendon G
Mulligan AM
Chanock SJ
Lissowska J
Liu J
Cox A
Cramp H
Connley D
Balasubramanian S
Dunning AM
Shah M
Trentham-Dietz A
Newcomb P
Titus L
Egan K
Cahoon EK
Rajaraman P
Sigurdson AJ
Doody MM
Guénel P
Pharoah PD
Schmidt MK
Hall P
Easton DF
Garcia-Closas M
Milne RL
Chang-Claude J
Pokaż więcej
Corporate Authors:
Genica Network
kConFab
AOCS Management Group
Źródło:
PLoS genetics [PLoS Genet] 2013; Vol. 9 (3), pp. e1003284. Date of Electronic Publication: 2013 Mar 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Gene-Environment Interaction*
Genetic Association Studies*
Breast Neoplasms/*genetics
Alleles ; Breast Neoplasms/pathology ; Caspase 8/genetics ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Microfilament Proteins/genetics ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk Factors ; White People
Czasopismo naukowe
Tytuł:
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Autorzy:
Couch FJ; Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Wang X
McGuffog L
Lee A
Olswold C
Kuchenbaecker KB
Soucy P
Fredericksen Z
Barrowdale D
Dennis J
Gaudet MM
Dicks E
Kosel M
Healey S
Sinilnikova OM
Lee A
Bacot F
Vincent D
Hogervorst FB
Peock S
Stoppa-Lyonnet D
Jakubowska A
Radice P
Schmutzler RK
Domchek SM
Piedmonte M
Singer CF
Friedman E
Thomassen M
Hansen TV
Neuhausen SL
Szabo CI
Blanco I
Greene MH
Karlan BY
Garber J
Phelan CM
Weitzel JN
Montagna M
Olah E
Andrulis IL
Godwin AK
Yannoukakos D
Goldgar DE
Caldes T
Nevanlinna H
Osorio A
Terry MB
Daly MB
van Rensburg EJ
Hamann U
Ramus SJ
Toland AE
Caligo MA
Olopade OI
Tung N
Claes K
Beattie MS
Southey MC
Imyanitov EN
Tischkowitz M
Janavicius R
John EM
Kwong A
Diez O
Balmaña J
Barkardottir RB
Arun BK
Rennert G
Teo SH
Ganz PA
Campbell I
van der Hout AH
van Deurzen CH
Seynaeve C
Gómez Garcia EB
van Leeuwen FE
Meijers-Heijboer HE
Gille JJ
Ausems MG
Blok MJ
Ligtenberg MJ
Rookus MA
Devilee P
Verhoef S
van Os TA
Wijnen JT
Frost D
Ellis S
Fineberg E
Platte R
Evans DG
Izatt L
Eeles RA
Adlard J
Eccles DM
Cook J
Brewer C
Douglas F
Hodgson S
Morrison PJ
Side LE
Donaldson A
Houghton C
Rogers MT
Dorkins H
Eason J
Gregory H
McCann E
Murray A
Calender A
Hardouin A
Berthet P
Delnatte C
Nogues C
Lasset C
Houdayer C
Leroux D
Rouleau E
Prieur F
Damiola F
Sobol H
Coupier I
Venat-Bouvet L
Castera L
Gauthier-Villars M
Léoné M
Pujol P
Mazoyer S
Bignon YJ
Złowocka-Perłowska E
Gronwald J
Lubinski J
Durda K
Jaworska K
Huzarski T
Spurdle AB
Viel A
Peissel B
Bonanni B
Melloni G
Ottini L
Papi L
Varesco L
Tibiletti MG
Peterlongo P
Volorio S
Manoukian S
Pensotti V
Arnold N
Engel C
Deissler H
Gadzicki D
Gehrig A
Kast K
Rhiem K
Meindl A
Niederacher D
Ditsch N
Plendl H
Preisler-Adams S
Engert S
Sutter C
Varon-Mateeva R
Wappenschmidt B
Weber BH
Arver B
Stenmark-Askmalm M
Loman N
Rosenquist R
Einbeigi Z
Nathanson KL
Rebbeck TR
Blank SV
Cohn DE
Rodriguez GC
Small L
Friedlander M
Bae-Jump VL
Fink-Retter A
Rappaport C
Gschwantler-Kaulich D
Pfeiler G
Tea MK
Lindor NM
Kaufman B
Shimon Paluch S
Laitman Y
Skytte AB
Gerdes AM
Pedersen IS
Moeller ST
Kruse TA
Jensen UB
Vijai J
Sarrel K
Robson M
Kauff N
Mulligan AM
Glendon G
Ozcelik H
Ejlertsen B
Nielsen FC
Jønson L
Andersen MK
Ding YC
Steele L
Foretova L
Teulé A
Lazaro C
Brunet J
Pujana MA
Mai PL
Loud JT
Walsh C
Lester J
Orsulic S
Narod SA
Herzog J
Sand SR
Tognazzo S
Agata S
Vaszko T
Weaver J
Stavropoulou AV
Buys SS
Romero A
de la Hoya M
Aittomäki K
Muranen TA
Duran M
Chung WK
Lasa A
Dorfling CM
Miron A
Benitez J
Senter L
Huo D
Chan SB
Sokolenko AP
Chiquette J
Tihomirova L
Friebel TM
Agnarsson BA
Lu KH
Lejbkowicz F
James PA
Hall P
Dunning AM
Tessier D
Cunningham J
Slager SL
Wang C
Hart S
Stevens K
Simard J
Pastinen T
Pankratz VS
Offit K
Easton DF
Chenevix-Trench G
Antoniou AC
Pokaż więcej
Corporate Authors:
kConFab Investigators
SWE-BRCA
Ontario Cancer Genetics Network
HEBON
EMBRACE
GEMO Study Collaborators
BCFR
CIMBA
Źródło:
PLoS genetics [PLoS Genet] 2013; Vol. 9 (3), pp. e1003212. Date of Electronic Publication: 2013 Mar 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Genome-Wide Association Study*
BRCA1 Protein/*genetics
Breast Neoplasms/*genetics
Ovarian Neoplasms/*genetics
BRCA2 Protein/genetics ; Breast Neoplasms/pathology ; Female ; Genetic Predisposition to Disease ; Genotype ; Heterozygote ; Humans ; Middle Aged ; Mutation ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
Autorzy:
Hein R; Unit of Genetic Epidemiology, Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. />Maranian M
Hopper JL
Kapuscinski MK
Southey MC
Park DJ
Schmidt MK
Broeks A
Hogervorst FB
Bueno-de-Mesquita HB
Muir KR
Lophatananon A
Rattanamongkongul S
Puttawibul P
Fasching PA
Hein A
Ekici AB
Beckmann MW
Fletcher O
Johnson N
dos Santos Silva I
Peto J
Sawyer E
Tomlinson I
Kerin M
Miller N
Marmee F
Schneeweiss A
Sohn C
Burwinkel B
Guénel P
Cordina-Duverger E
Menegaux F
Truong T
Bojesen SE
Nordestgaard BG
Flyger H
Milne RL
Perez JI
Zamora MP
Benítez J
Anton-Culver H
Ziogas A
Bernstein L
Clarke CA
Brenner H
Müller H
Arndt V
Stegmaier C
Rahman N
Seal S
Turnbull C
Renwick A
Meindl A
Schott S
Bartram CR
Schmutzler RK
Brauch H
Hamann U
Ko YD
Wang-Gohrke S
Dörk T
Schürmann P
Karstens JH
Hillemanns P
Nevanlinna H
Heikkinen T
Aittomäki K
Blomqvist C
Bogdanova NV
Zalutsky IV
Antonenkova NN
Bermisheva M
Prokovieva D
Farahtdinova A
Khusnutdinova E
Lindblom A
Margolin S
Mannermaa A
Kataja V
Kosma VM
Hartikainen J
Chen X
Beesley J
Lambrechts D
Zhao H
Neven P
Wildiers H
Nickels S
Flesch-Janys D
Radice P
Peterlongo P
Manoukian S
Barile M
Couch FJ
Olson JE
Wang X
Fredericksen Z
Giles GG
Baglietto L
McLean CA
Severi G
Offit K
Robson M
Gaudet MM
Vijai J
Alnæs GG
Kristensen V
Børresen-Dale AL
John EM
Miron A
Winqvist R
Pylkäs K
Jukkola-Vuorinen A
Grip M
Andrulis IL
Knight JA
Glendon G
Mulligan AM
Figueroa JD
García-Closas M
Lissowska J
Sherman ME
Hooning M
Martens JW
Seynaeve C
Collée M
Hall P
Humpreys K
Czene K
Liu J
Cox A
Brock IW
Cross SS
Reed MW
Ahmed S
Ghoussaini M
Pharoah PD
Kang D
Yoo KY
Noh DY
Jakubowska A
Jaworska K
Durda K
Złowocka E
Sangrajrang S
Gaborieau V
Brennan P
McKay J
Shen CY
Yu JC
Hsu HM
Hou MF
Orr N
Schoemaker M
Ashworth A
Swerdlow A
Trentham-Dietz A
Newcomb PA
Titus L
Egan KM
Chenevix-Trench G
Antoniou AC
Humphreys MK
Morrison J
Chang-Claude J
Easton DF
Dunning AM
Pokaż więcej
Corporate Authors:
GENICA Network
Kconfab Investigators
AOCS Group
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (8), pp. e42380. Date of Electronic Publication: 2012 Aug 07.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Genetic Predisposition to Disease*
Genome-Wide Association Study*
Breast Neoplasms/*genetics
Chromosomes, Human, Pair 6/*genetics
Polymorphism, Single Nucleotide/*genetics
Asia ; Europe ; Female ; Haplotypes/genetics ; Humans ; Linkage Disequilibrium/genetics ; Receptors, Estrogen/genetics ; Risk Factors
Czasopismo naukowe
Tytuł:
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Autorzy:
Gaudet MM; Department of Epidemiology and Population Health and Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, New York, New York, United States of America.
Kirchhoff T
Green T
Vijai J
Korn JM
Guiducci C
Segrè AV
McGee K
McGuffog L
Kartsonaki C
Morrison J
Healey S
Sinilnikova OM
Stoppa-Lyonnet D
Mazoyer S
Gauthier-Villars M
Sobol H
Longy M
Frenay M
GEMO Study Collaborators
Hogervorst FB
Rookus MA
Collée JM
Hoogerbrugge N
van Roozendaal KE
Piedmonte M
Rubinstein W
Nerenstone S
Van Le L
Blank SV
Caldés T
de la Hoya M
Nevanlinna H
Aittomäki K
Lazaro C
Blanco I
Arason A
Johannsson OT
Barkardottir RB
Devilee P
Olopade OI
Neuhausen SL
Wang X
Fredericksen ZS
Peterlongo P
Manoukian S
Barile M
Viel A
Radice P
Phelan CM
Narod S
Rennert G
Lejbkowicz F
Flugelman A
Andrulis IL
Glendon G
Ozcelik H
Toland AE
Montagna M
D'Andrea E
Friedman E
Laitman Y
Borg A
Beattie M
Ramus SJ
Domchek SM
Nathanson KL
Rebbeck T
Spurdle AB
Chen X
Holland H
John EM
Hopper JL
Buys SS
Daly MB
Southey MC
Terry MB
Tung N
Overeem Hansen TV
Nielsen FC
Greene MH
Mai PL
Osorio A
Durán M
Andres R
Benítez J
Weitzel JN
Garber J
Hamann U
Peock S
Cook M
Oliver C
Frost D
Platte R
Evans DG
Lalloo F
Eeles R
Izatt L
Walker L
Eason J
Barwell J
Godwin AK
Schmutzler RK
Wappenschmidt B
Engert S
Arnold N
Gadzicki D
Dean M
Gold B
Klein RJ
Couch FJ
Chenevix-Trench G
Easton DF
Daly MJ
Antoniou AC
Altshuler DM
Offit K
Pokaż więcej
Corporate Authors:
HEBON Study Collaborators
OCGN
kConFab
EMBRACE
Źródło:
PLoS genetics [PLoS Genet] 2010 Oct 28; Vol. 6 (10), pp. e1001183. Date of Electronic Publication: 2010 Oct 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Polymorphism, Single Nucleotide*
BRCA2 Protein/*genetics
Breast Neoplasms/*genetics
Genome-Wide Association Study/*methods
Adult ; Chromosomes, Human, Pair 10 ; Chromosomes, Human, Pair 20 ; DNA-Binding Proteins/genetics ; Female ; Gene Frequency ; Genetic Predisposition to Disease/genetics ; Haplotypes ; Heterozygote ; Humans ; Linkage Disequilibrium ; Middle Aged ; Mutation ; Penetrance ; Receptor, Fibroblast Growth Factor, Type 2/genetics ; Risk Factors ; Transcription Factors/genetics ; White People/genetics
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies